Cannabis Report
Lithium
Home > Boards > US Listed > Medical - Equipment >

InspireMD, Inc. (NSPR)

NSPR RSS Feed
Add NSPR Price Alert      Hide Sticky   Hide Intro
Moderator: Value_Investor
Search This Board: 
Last Post: 8/15/2018 4:29:44 PM - Followers: 78 - Board type: Free - Posts Today: 0

 

Great Europe-Patent News for NSPR (01.05.2017):
 https://register.epo.org/application?number=EP07827415

NSPR is still one of the Cheapest NYSE stocks based on the New BV & CV! The 10-Q confirms its 100% Debt-Free financial status which is the most important fundamental for a big board stock ! 

https://register.epo.org/application?number=EP07827415 
https://finance.yahoo.com/news/inspiremd-announces-distribution-agreement-cguard-113000992.html 
http://finance.yahoo.com/news/inspiremd-announces-distribution-agreement-cguard-110000931.html 
http://finance.yahoo.com/news/inspiremd-cguard-tm-embolic-prevention-133200180.html 
http://www.marketwatch.com/story/inspiremd-repays-term-note-ahead-of-schedule-2017-03-22?siteid=bigcharts&dist=bigcharts 


InspireMD was founded in 2005 with the purpose of creating a technology that could solve the problem of embolization in high risk vascular procedures. The company has grown to include a portfolio of embolic protection systems, which it both manufactures and commercializes.

Today, InspireMD is a global company headquartered in Boston, MA. InspireMD seeks to utilize its proprietary MicroNetTM technology to make its products the industry standard for embolic protection by providing a superior solution to the key clinical issues of vascular procedures.
 

Our Technology

MicroNetTM

The MicroNet is a bio-stable mesh woven from a single strand of 20 μm Polyethylene Terephthalate (PET). The MicroNet is designed to trap and seal thrombus and plaque against the vessel wall, preventing embolization.

MicroNetTM key features:

  • PET is a bio-stable synthetic fiber widely used in a variety of industries.
    Attached and secured to the proximal and the distal crowns of the stent.
    Does not alter the procedure as it expands with the stent.
    Pore size is typically between 150 – 180 µm. 
     

CGuard™

need for tapered version


Carotid Embolic Prevention System

The CGuardTM Embolic Prevention System (EPS) is designed to prevent peri-procedural and late embolization by trapping potential emboli against the arterial wall while maintaining excellent perfusion to the external carotid artery and branch vessels.

Product Details:

  • CGuard material: Nitinol
MicroNet material: Polyethylene Terephthalate (PET)
  • Easy to use RX (Rapid Exchange) delivery system
     

MGuard™

Improving Clinical Outcomes For STEMI Patients

The MGuardTM Embolic Protection System (EPS), integrated with MicroNetTM  (see Our Technology), is designed to trap and seal thrombus and ruptured plaque, prevent distal embolization and optimize flow.

While offering performance that is superior to standard STEMI therapy, MGuard requires no change in current physician practice – an important factor in time-critical settings.

 

Product Details:

  • MGuard material: Stainless Steel 316 
  • MicroNet material: Polyethylene Terephthalate (PET)

     

MGuard Prime™

Improving Clinical Outcomes For STEMI Patients

The MGuard PrimeTM Embolic Protection System (EPS), integrated with MicroNetTM  (see Our Technology), is designed to trap and seal thrombus and ruptured plaque, prevent distal embolization, and optimize flow, while ensuring excellent deliverabililty.

While offering performance that is superior to standard STEMI therapy, MGuard Prime requires no change in current physician practice – an important factor in time-critical settings.

 

Product Details:

  • MGuard Prime material: Cobalt Chromium (CoCr) L605

MicroNet material: Polyethylene Terephthalate (PET)
  • Superior flexibility and excellent deliverability

http://www.inspiremd.com/en/products/the-technology/
 

2017 News

Thursday23March 2017

InspireMD’s CGuard™ Carotid Embolic Prevention System to be Featured at ICCA Stroke 2017 in Moscow, Russia

BOSTON, MA—March 23, 2017 – InspireMD, Inc. (NYSE MKT:NSPR) (NYSE MKT:NSPR.WS) (“InspireMD” or the “Company”), a leader in embolic prevention systems (EPS), neurovascular devices and thrombus management technologies, today announced that its…

Wednesday22March 2017

InspireMD Repays Term Note Ahead of Schedule

Tel Aviv—March 22, 2017 – InspireMD, Inc. (NYSE MKT:NSPR) (NYSE MKT:NSPR.WS) (“InspireMD” or the “Company”), a leader in embolic prevention systems (EPS) / thrombus management technologies and neurovascular devices, today announced that…

Tuesday21March 2017

InspireMD Announces Distribution Agreement for CGuard™ EPS in Hong Kong

BOSTON, MA—March 21, 2017 – InspireMD, Inc. (NYSE MKT:NSPR) (NYSE MKT:NSPR.WS) (“InspireMD” or the “Company”), a leader in embolic prevention systems (EPS) / thrombus management technologies and neurovascular devices, today announced it…

Monday20March 2017

InspireMD Announces CGuardTM Distribution Agreement for the Russian Federation

Tel Aviv—March 20, 2017 – InspireMD, Inc. (NYSE MKT:NSPR) (NYSE MKT:NSPR.WS) (“InspireMD” or the “Company”), a leader in embolic prevention systems (EPS) / thrombus management technologies and neurovascular devices, today announced it…

Wednesday15March 2017

InspireMD Reports Continued Progress in the Transition of European Sales and Distribution

Announces Agreements with Leading Distributors in the Baltic States   BOSTON, MA—March 15, 2017 – InspireMD, Inc. (NYSE MKT:NSPR) (NYSE MKT:NSPR.WS) (“InspireMD” or the “Company”), a leader in embolic prevention systems (EPS)…

Tuesday14March 2017

InspireMD Announces Closing of Public Offering of Approximately $6.8 Million

BOSTON, MA – March 14, 2017 – InspireMD, Inc. (NYSE MKT: NSPR) (“InspireMD” or the “Company”), a leader in embolic prevention systems (EPS) / thrombus management technologies and neurovascular devices,…

Thursday09March 2017

InspireMD Announces Pricing of Public Offering of up to $7.5 Million

BOSTON, MA – March 9, 2017 – InspireMD, Inc. (NYSE MKT: NSPR) (“InspireMD” or the “Company”), a leader in embolic prevention systems (EPS) / thrombus management technologies and neurovascular devices,…

Thursday16February 2017

InspireMD Provides Year End Business Update and Reports Financial Results for the Fourth Quarter and Year Ended December 31, 2016

Transition from Exclusive Distribution Partner to Local Distributors and Internal Sales Strategy Validated by Strong Revenue Growth in Select Markets   BOSTON, MA—February 16, 2017 – InspireMD, Inc. (NYSE MKT:NSPR) (NYSE MKT:NSPR.WS)…

Tuesday24January 2017

InspireMD’s CGuard™ Carotid Embolic Prevention System to be Featured at LINC 2017

PD Dr. Andrej Schmidt to perform live case transmission of carotid stent surgery utilizing CGuard™ BOSTON, MA– January 24, 2016 – InspireMD, Inc. (NYSE MKT:NSPR) (NYSE MKT:NSPR.WS) (“InspireMD” or the “Company”), a…

Contact Us

Thank you for your interest in InspireMD, please let us know how we can help you. You can contact us at info@inspiremd.com or 1-888-776-6804.

Executives

James J. BarryPresident & Chief Executive Officer

Dr. Barry has over 20 years of experience in the medical device industry. Prior to joining InspireMD, he was the President and CEO of Arsenal Medical, a life sciences company…

Craig ShoreChief Financial Officer

Mr. Shore has over 25 years of experience in financial management in the United States, Europe and Israel. He has served in various senior financial and general management roles at…

Agustin GagoExecutive Vice President and Chief Commercial Officer

Mr. Gago has over 25 years of experience in building profitable international commercial, sales and marketing organizations. Prior to joining InspireMD, he was the founder and principal of Dash International…

Benzi SpectorHead of R&D and Operations

Mr. Spector has more than 25 years of experience in research, development and engineering, serving as the lead on a range of product lines and systems in the healthcare space….

Sharon ShacharHead of Regulatory and Quality

Mrs. Shachar has over 12 years of experience in quality, regulatory and clinical execution, serving in executive roles in small and large medical companies.   Prior to joining InspireMD, she…

Website:  http://www.inspiremd.com/en/

 

Cannabis Report
Lithium
NSPR
Current Price
Volume:
Bid Ask Day's Range
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
PlusOneCoin Top Posts
No plusone'd posts yet. Be the first!
PostSubject
#1789  Sticky Note NSPR crashed to $0.17 so far! We might Value_Investor 08/14/18 09:24:21 AM
#1791   I don't know man....delisting may discount them a 420man 08/15/18 04:29:43 PM
#1790   Glad to see NSPR hit a New 52-week Value_Investor 08/15/18 01:07:36 PM
#1789   NSPR crashed to $0.17 so far! We might Value_Investor 08/14/18 09:24:21 AM
#1788   NSPR ever hit the New low $0.19 in Value_Investor 08/11/18 03:09:28 PM
#1787   Nice to see $0.2052 today! Hopefully tomorrow I Value_Investor 08/09/18 09:43:09 PM
#1786   Yes, $0.23 seems the New bottom support! They Value_Investor 08/07/18 11:33:07 AM
#1785   It seems "not good" at all because NSPR Value_Investor 08/07/18 08:27:36 AM
#1784   Will wait for next quater earnings to see 420man 08/07/18 08:15:55 AM
#1783   I will be watching.. The new lenders own 420man 08/07/18 07:49:17 AM
#1782   'Value_Investor', earnings conference call tomorrow @ 8:00 am pennyvestor 08/06/18 07:56:46 PM
#1781   NSPR exploded to $0.28 in the After-Hour session! Value_Investor 08/06/18 07:39:34 PM
#1780   Nice to see this NYSE Pos Scam hit Value_Investor 08/06/18 03:23:51 PM
#1779   If and when the stock gets to .60 tomsen 08/06/18 11:35:44 AM
#1778   Here is the reason why this crap CEO Value_Investor 08/04/18 06:49:33 PM
#1777   These Companies and their lenders are the predators, 420man 08/03/18 07:14:03 PM
#1776   It seems 0.22 will be another New top Value_Investor 08/03/18 04:52:46 PM
#1774   I feel for what you said about the tomsen 08/02/18 05:14:11 PM
#1773   I may buy in a couple more weeks 420man 08/02/18 12:14:14 PM
#1772   Finally the Biggest Pos Scam bounced 10% from Value_Investor 08/02/18 11:30:16 AM
#1771   Another New 52-week low $0.2 was created! Sell Value_Investor 08/01/18 01:42:44 PM
#1770   Totally 1,245,200 shares were shorted on July 13, Value_Investor 07/26/18 12:50:23 PM
#1769   InspireMD Announces Opening of First Two CGuard™ EPS Value_Investor 07/24/18 08:49:48 AM
#1768   Totally 579,100 shares were shorted on July 15, Value_Investor 07/19/18 11:57:37 PM
#1767   Slide presentation: Three2001 07/09/18 07:28:32 PM
#1766   I got you loud and clear, but I 420man 06/29/18 11:29:29 PM
#1765   Agreed....even IF this bounced it would be futile 420man 06/29/18 11:17:14 PM
#1764   NSPR has already crashed to a New 52-week Value_Investor 06/29/18 11:11:36 PM
#1763   * * $NSPR Video Chart 06-29-18 * * ClayTrader 06/29/18 05:10:18 PM
#1762   Lol - never doncamel 06/29/18 04:51:21 PM
#1761   Yep, just don't overstay your welcome.... Rymankoly 06/29/18 04:50:48 PM
#1760   So basic cycle of death... but still say doncamel 06/29/18 04:40:38 PM
#1759   Just look at the 5 year chart, the Rymankoly 06/29/18 04:39:12 PM
#1758   Will be back in a month or so 420man 06/29/18 04:39:01 PM
#1757   Because this is lower than the bottom of doncamel 06/29/18 03:17:15 PM
#1756   Why? mikekrane 06/29/18 03:16:03 PM
#1755   Anything under .25- buy doncamel 06/29/18 03:11:02 PM
#1754   What happened to this scam today? Big dump.. mikekrane 06/29/18 03:05:54 PM
#1753   Well I'm done looking at it.. if it king koopa 06/29/18 11:03:41 AM
#1752   I agree! I feel sick to my stomach 420man 06/29/18 10:52:41 AM
#1751   Well, I lost a little bit but I 420man 06/29/18 10:48:06 AM
#1750   Both of you are d!cks then. Three2001 06/29/18 10:45:34 AM
#1749   You did- nice call doncamel 06/29/18 10:44:11 AM
#1748   As I predicted... https://investorshub.advfn.com/boards/read_msg.aspx?message_id=141746981 420man 06/29/18 10:42:49 AM
#1747   No it’s just the offering- nobody trusts management anymore doncamel 06/29/18 10:41:05 AM
#1746   Now I'm wondering if the Cguard came to king koopa 06/29/18 10:40:22 AM
#1745   Your right- others got hit hard here. doncamel 06/29/18 10:39:50 AM
#1744   Btw, this is NOT a scam. It’s a PickleNick 06/29/18 10:38:18 AM
#1743   What happened here? Been following this one since PickleNick 06/29/18 10:37:57 AM
#1742   $1.20 is NOTHING compared to what I'm in Three2001 06/29/18 10:37:21 AM
#1741   RS, drop, offering, RS , DROP offering- they’re doncamel 06/29/18 10:33:54 AM
PostSubject